Nanomedicine: future therapy for brain cancers

Haque, Shagufta; Norbert, Caroline Celine; Patra, Chitta Ranjan

doi:10.1016/b978-0-12-819793-6.00003-5

Cited by 3 publications

(1 citation statement)

References 119 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Bioplastic NPs have emerged also as a strategy for the treatment of brain cancers such as glioblastoma which is considered the most aggressive form of CNS tumors [165,166]. In a study carried out by Maksimenko et al [167], it emerged that PLGA-NPs (size 110 nm), loaded with doxorubicin and coated with poloxamer 188 (Dox-PLGA), crossed the BBB more efficiently than doxorubicin alone in a xenograft rat model.…”

Section: Bioplastic Mps/nps For Brain Diseases: Advantagesmentioning

confidence: 99%

The Other Side of Plastics: Bioplastic-Based Nanoparticles for Drug Delivery Systems in the Brain

Lamparelli,

Marino,

Szychlinska

et al. 2023

Pharmaceutics

View full text Add to dashboard Cite

Plastics have changed human lives, finding a broad range of applications from packaging to medical devices. However, plastics can degrade into microscopic forms known as micro- and nanoplastics, which have raised concerns about their accumulation in the environment but mainly about the potential risk to human health. Recently, biodegradable plastic materials have been introduced on the market. These polymers are biodegradable but also bioresorbable and, indeed, are fundamental tools for drug formulations, thanks to their transient ability to pass through biological barriers and concentrate in specific tissues. However, this “other side” of bioplastics raises concerns about their toxic potential, in the form of micro- and nanoparticles, due to easier and faster tissue accumulation, with unknown long-term biological effects. This review aims to provide an update on bioplastic-based particles by analyzing the advantages and drawbacks of their potential use as components of innovative formulations for brain diseases. However, a critical analysis of the literature indicates the need for further studies to assess the safety of bioplastic micro- and nanoparticles despite they appear as promising tools for several nanomedicine applications.

show abstract

Section: Bioplastic Mps/nps For Brain Diseases: Advantagesmentioning

confidence: 99%